Category Archives: Healthcare

Algae Dynamics Corp Announces Research Agreement With University of Western Ontario to Investigate the Use of Cannabis Derivatives for the Development of Novel Pharmacotherapies for Mental Health

Algae Dynamics announces a development agreement with Western University to do research on cannabis oil in the context of depression, post-traumatic stress disorder & schizophrenia.

Toronto, Canada — ALGAE DYNAMICS CORP (OTCQB: ADYNF) (the “Company”), a development stage company focused on the development of unique health products and pharmaceuticals utilizing cannabis and algae oils, today announced a research and product development agreement with Western University to perform research on cannabis oil and its constituents in the context of depression, post-traumatic stress disorder, anxiety and schizophrenia. This is the second of the recently announced research agreements with Canadian universities involving cannabis oil research. This announcement brings Algae Dynamics total university research contributions to $1.6 million for both programs.

This announcement follows the Company’s previously announced new strategic initiative to explore the extraction of oils from other botanicals, most notably cannabis, and to seek product development and formulation opportunities that combine the benefits of algae and cannabis oils. This research agreement will directly support this initiative and will “focus on translational pharmaceutical research, with a specific focus on identifying how specific phytochemical compounds found in cannabis, including delta-9-tetrahydrocannbinol (THC), cannabidiol (CBD), cannabinoid-derived terpenoids and other potential phytochemical derivatives of cannabis may serve as novel pharmacological treatments for symptoms associated with depression, post-traumatic stress disorder, anxiety and schizophrenia.”

Paul Ramsay, Chairman and President of the Company said, “With this research agreement, we are building upon the previously announced strategic initiative into the use of extracts from cannabis oil, in conjunction with algae oil, to develop unique health products and formulations. In our previous press release, we outlined a three-part approach, the first being Research and Development work with Canadian universities. This is the second of such research agreements relating to the use of botanical extracts including cannabinoids that we expect to employ”.

The investigator leading the research is Dr. Steven Laviolette, a Professor and Neuroscientist in the Schulich School of Medicine & Dentistry at Western University. Dr. Laviolette is a leader in the study of cannabinoids in mental health. Dr. Laviolette’s research team has previously made numerous fundamental discoveries related to how cannabinoids impact and may serve as treatments for mental health disorders including schizophrenia, depression, post-traumatic stress disorder and anxiety. Dr. Laviolette’s primary research focus is in characterizing how specific phytochemical derivatives of cannabis may interact with specific brain pathways and molecular mechanisms whereby they may improve symptoms associated with various mental health disorders. Research from Dr. Laviolette’s team has been published in the top neuroscience and psychiatry journals in the world. His full profile may be seen on the Western University, website http://www.uwo.ca:

http://www.schulich.uwo.ca/anatomy/people/bios/faculty/laviolette_steve.html

The Company’s contribution to the four-year Sponsored Research Agreement, which commences April 1, 2017 and terminates March 30, 2021, is C$250,000 per year. The Company believes, from past experience, that it will be able to leverage the research expenditures with matching scientific grants pursuant to programs of various branches of government. The Company will be responsible for the filing of patents relating to this research and will own such patents if and when issued. The Company has agreed to make payments to the University upon filing of each patent, when each patent is issued, after first commercial sale and when gross sales reach C$1,000,000. There are no ongoing royalty payments, relating to the use of the patents. The workplan may be extended and modified to achieve best outcomes which may include 1) delegating specific research areas of research work that require additional technologies to appropriate providers; and 2) engaging research collaborators to extend the research into additional areas of benefit to the Company.

The Company’s core product development strategy has been the production of high volume specific algae species and extraction of Essential Fatty Acids (EFAs) which is the foundation of the endocannabinoid system (ECS). The ECS is a group of endogenous cannabinoid receptors located in the mammalian brain and throughout the central and peripheral nervous systems, consisting of neuromodulatory lipids and their receptors. The extracted algae Omega 3 oil with high concentrations of DHA is used as a health supplement product. In light of the potential synergies, the Company has developed its strategy which is aimed at developing new products and formulations that combine the health benefits of algae and cannabis oils.

As reported earlier, the Company is continuing to seek opportunities to partner with or take ownership in existing Access to Cannabis for Medical Purposes Regulations (ACMPR) licensed producers to allow for access to the marketplace.

About Algae Dynamics Corp
ADC is currently engaged in the development of unique health products and pharmaceuticals that utilize hemp, cannabis and algae oils. This is an extension of our plan to commercialize our proprietary BioSilo® algae cultivation system for the high volume, low cost production of pure contaminant-free algae biomass which is high in Omega-3 fatty acids. We have engaged two Canadian universities to provide research into the use of extracts from cannabis oil, which we plan to use to develop products that combine the significant health benefits of Omega-3s derived from algae oil and extracts from cannabis oil. Our research is focusing on the use of cannabis oil in the context of cancer, and the use of cannabis derivatives for the development of novel pharmacotherapies for mental health.

NOTE REGARDING FORWARD-LOOKING STATEMENTS
This news release contains “forward-looking statements” as that term is defined in Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, use of proceeds and the development, costs and results of current or future actions and opportunities in the sector. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies, our ability to raise the additional funding we will need to continue to pursue our exploration and development program, and our ability to retain important members of our management team and attract other qualified personnel. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.

FOR MORE INFORMATION, PLEASE CONTACT:
Paul Ramsay
Phone: 289-997-6740
Email: ramsay(at)algaedynamics.com
http://www.algaedynamics.com

Monterey Peninsula Surgery Centers Launches Minimus Institute

MPSC extends its quality outpatient care nationally with Minimus Institute, a national referral center offering patient-focused surgical care in a concierge setting

Monterey, CA, March 03, 2017 — Monterey Peninsula Surgery Centers (MPSC), a highly respected surgical care provider and the largest locally-owned outpatient surgery organization in California, performs nearly 17,000 surgical procedures in 13 specialties annually. Every day more than 70 individuals and their families trust MPSC for their surgical care. MPSC’s esteemed team of surgeons, anesthesiologists, nurses and patient service providers have been delivering extraordinary care to the communities of Monterey, Salinas and Santa Cruz for over 35 years.

MPSC and its surgeons are recognized leaders in outpatient surgical care as measured by the high demand for its services, extremely low infection rates, 99% patient-satisfaction scores and affordable, transparent pricing. If MPSC was a hospital, it would rank No. 4 in the state in the number of outpatient surgeries performed annually.

Although the majority of MPSC’s patients reside in Northern and Central California, in the last five years, MPSC has attracted patients from 47 states and 10 countries seeking the most advanced surgical care.

Now, through Minimus Institute, which launched November 2016, MPSC is extending its services to patients living outside the Monterey, Santa Cruz and Salinas areas. Through Minimus Institute, MPSC will meet the unique pre and post-operative needs of patients traveling for surgery, including facilitating the surgeon-patient relationship, arranging physician consultations and booking travel accommodations, to ensure patients receive a stress-free experience. Since its launch last year, Minimus Institute has served patients from Oregon, Alaska and throughout California.

Minimus is a national surgery referral center that offers access to world-class surgeons and arms patients with real-time data on outcomes, infection rates, patient satisfaction scores and transparent pricing, all in a concierge setting. Minimus Institute strives to empower patients to make the most informed decisions about their care and guide them through their surgical experience.

Minimus Institute will begin with spinal surgery, but will expand to include orthopedic surgery, general surgery, gynecologic surgery and many other specialties.

“Patients can visit our website at MinimusInstitute.com to view up-front, all-inclusive pricing, patient satisfaction scores and infection rates to help them make an informed decision regarding their surgery options,” said Thomas D. Wilson, Managing Partner and CEO of MPSC and Minimus Institute. “Minimus provides patients an outstanding surgical experience with great value as measured by an optimum combination of quality, service and price. Because surgery is all we do, our hallmarks are efficiency, clarity and excellence. Our goal is to deliver surgery a better way. We strive to be pioneers in arming our patients with knowledge and we want to enable patients to make well-informed decisions.”

By leveraging the organization’s high-quality care and excellent patient experience with transparent pricing and outcomes, Minimus seeks to demystify the patient/surgery/doctor interaction.

Minimus‘ prime objective is to become recognized as a national destination surgery center or “beacon” for patients, insurance companies and self-insured groups seeking the most advanced and least invasive outpatient surgery in a setting featuring transparency, value and great outcomes. Patients can also access up-front, all-inclusive surgical pricing at http://minimusinstitute.com/procedures/.

About Minimus Institute:

Minimus Institute is a national state-of-the-art surgical institute located in a beautiful setting on California’s Central Coast, providing patients access to world-class surgeons and exceptional value. Offering transparent pricing and clear, comprehensive outcome information and patient-satisfaction scores, Minimus demystifies the surgical-care experience allowing patients to make the most informed decisions about their care. To learn more go to http://minimusinstitute.com/.

About Monterey Peninsula Surgery Centers (MPSC):

MPSC and its surgeons are recognized leaders in outpatient surgical care as measured by the high demand for its services, extremely low infection rates, 99% patient satisfaction scores and affordable, transparent pricing. It is known for performing complex surgery, including total joint replacements, major spine surgeries, hysterectomies, breast reconstruction and thyroidectomies in the outpatient setting. In excess of 31,500 surgical procedures across 13 specialties are performed annually at MPSC by its 190 physicians on staff.

High Resolution Photos Available: https://www.dropbox.com/sh/zo7s0a27obvtu3x/AACyJlJ5-2eFvdzSOg4awhUwa?dl=0

Contact:

Marci Bracco Cain

Chatterbox PR

Salinas, CA 93901

(831) 747-7455

http://minimusinstitute.com/

San Joaquin Valley Residents Can Now Take Advantage of Monterey, California-Based Minimus Institute’s Patient-Focused Surgical Care, World-Class Surgeons, Innovative Transparent Pricing and Outcome Reporting System, offered in a Concierge Setting

Minimus Institute, a Monterey, California-based national referral center offering state-of-the-art outpatient surgery to patients and self-insured groups throughout the country

Monterey, CA, March 02, 2017 — Minimus Institute, a Monterey, California-based national referral center offering state-of-the-art outpatient surgery to patients and self-insured groups throughout the country, is now taking patients from San Joaquin County including Fresno, Tulare, SLO, Madera, Merced, Mariposa and Stanislaus and is the first surgery center to offer county residents transparent pricing on its website http://minimusinstitute.com/pricing/.

With Minimus, San Joaquin County residents can travel to the beautiful coastal city of Monterey and receive nationally renowned patient-focused surgical care in a concierge setting, featuring world-class surgeons and an innovative transparent pricing and outcome reporting system.

Although the majority of their patients reside in Northern and Central California, in the last five years, Monterey Peninsula Surgery Centers (home of Minimus Institute), has become a national center, attracting patients from 47 states and 10 countries seeking the most advanced minimally invasive surgery.

“Patients can visit our website at MinimusInstute.com to view prices, patient satisfaction scores and infection rates to help them make an informed decision regarding their surgery options,” said Thomas D. Wilson, Managing Partner and CEO of Minimus Institute/MPSC. “Minimus provides patients an outstanding surgical experience with great value as measured by an optimum combination of quality, service and price. Because surgery is all we do, our hallmarks are efficiency, clarity and excellence. Our goal is to deliver surgery a better way. We strive to be pioneers in arming our patients with knowledge and we want to enable patients to make well-informed decisions.”

By leveraging the organization’s high-quality care, excellent patient experience combined with transparent pricing and outcomes, Minimus seeks to demystify the patient/surgery/doctor interaction.

Minimus’ prime objective is to become recognized as a national destination surgery center, or “beacon,” for patients, insurance companies and self-insured groups seeking the most advanced and least invasive outpatient surgery in a setting featuring transparency, value and great outcomes.

At Minimus, surgical care is provided at one of Monterey Peninsula Surgical Center’s locations around Monterey Bay. MPSC is the largest locally-owned outpatient healthcare facility in California, performing nearly 17,000 surgical cases annually. Every day more than 70 individuals and their families trust MPSC for their care. And, their esteemed team of surgeons and staff have been supporting patients for more than 35 years.

With Minimus, distance is not an obstacle to keep patients from the surgery they deserve. It is surgery and care worth traveling for.

Minimus Institute:

Minimus Institute is a national state-of-the-art surgical institute located in a beautiful setting on California’s Central Coast, providing patients access to world-class surgeons and exceptional value. Offering transparent pricing and clear, comprehensive outcome information and patient-satisfaction scores, Minimus demystifies the surgical-care experience allowing patients to make the most informed decisions about their care. To learn more go to http://minimusinstitute.com/.

Background on Monterey Peninsula Surgery Centers:

Monterey Peninsula Surgery Centers (MPSC) and its surgeons are recognized leaders in outpatient surgical care as measured by the high demand for its services, extremely low infection rates, 99% patient satisfaction scores and affordable, transparent pricing.

MPSC is known for performing complex surgery, including total joint replacements, major spine surgeries, hysterectomies, breast reconstruction and thyroidectomies in the outpatient setting. In excess of 31,500 surgical procedures in 13 specialties are performed annually at MPSC by its 190 physicians on staff.

Contact:

Marci Bracco Cain

Chatterbox PR

Salinas, CA 93901

(831) 747-7455

http://minimusinstitute.com/

Alaskan Residents Can Now Take Advantage of Monterey, California-Based Minimus Institute’s Patient-Focused Surgical Care, World-Class Surgeons, Innovative Transparent Pricing and Outcome Reporting System in a Concierge Setting

Minimus Institute, a Monterey, California-based national referral center offering state-of-the-art outpatient surgery to patients and self-insured groups throughout the country

Monterey, CA, March 02, 2017 — Minimus Institute, a Monterey, California-based national referral center offering state-of-the-art outpatient surgery to patients and self-insured groups throughout the country, is now taking patients from Alaska and is the first surgery center to offer Alaska residents transparent pricing on its website http://minimusinstitute.com/pricing/.

With Minimus, Alaskans can fly to the beautiful coastal city of Monterey and receive nationally renowned patient-focused surgical care in a concierge setting, featuring world-class surgeons and an innovative transparent pricing and outcome reporting system.

Although the majority of their patients reside in Northern and Central California, in the last five years, Monterey Peninsula Surgery Centers (home of Minimus Institute), has become a national center attracting patients from 47 states and 10 countries seeking the most advanced minimally invasive surgery.

“Patients can visit our website at MinimusInstute.com to view prices, patient satisfaction scores and infection rates to help them make an informed decision regarding their surgery options,” said Thomas D. Wilson, Managing Partner and CEO of Minimus Institute. “Minimus provides patients an outstanding surgical experience with great value as measured by an optimum combination of quality, service and price. Because surgery is all we do, our hallmarks are efficiency, clarity and excellence. Our goal is to deliver surgery a better way. We strive to be pioneers in arming our patients with knowledge and we want to enable patients to make well-informed decisions.”

By leveraging the organization’s high-quality care, excellent patient experience combined with transparent pricing and outcomes, Minimus seeks to demystify the patient/surgery/doctor interaction.

Minimus’ prime objective is to become recognized as a national destination surgery center, or “beacon,” for patients, insurance companies and self-insured groups seeking the most advanced and least invasive outpatient surgery in a setting featuring transparency, value and great outcomes.

At Minimus, surgical care is provided at one of Monterey Peninsula Surgical Centers’ locations around Monterey Bay. MPSC is the largest locally-owned outpatient healthcare facility in California, performing nearly 17,000 surgical cases annually. Every day more than 70 individuals and their families trust MPSC for their care. And, their esteemed team of surgeons and staff have been supporting patients for more than 35 years.

With Minimus, distance is not an obstacle to keep patients from the surgery they deserve. It is surgery and care worth traveling for.

Minimus Institute:

Minimus Institute is a national state-of-the-art surgical institute located in a beautiful setting on California’s Central Coast, providing patients access to world-class surgeons and exceptional value. Offering transparent pricing and clear, comprehensive outcome information and patient-satisfaction scores, Minimus demystifies the surgical-care experience allowing patients to make the most informed decisions about their care. To learn more go to http://minimusinstitute.com/.

Background on Monterey Peninsula Surgery Centers:

Monterey Peninsula Surgery Centers (MPSC) and its surgeons are recognized leaders in outpatient surgical care as measured by the high demand for its services, extremely low infection rates, 99% patient satisfaction scores and affordable, transparent pricing.

MPSC is known for performing complex surgery, including total joint replacements, major spine surgeries, hysterectomies, breast reconstruction and thyroidectomies in the outpatient setting. In excess of 31,500 surgical procedures in 13 specialties are performed annually at MPSC by its 190 physicians on staff.

High Resolution Photos Available: https://www.dropbox.com/sh/zo7s0a27obvtu3x/AACyJlJ5-2eFvdzSOg4awhUwa?dl=0

Contact:

Marci Bracco Cain

Chatterbox PR

Salinas, CA 93901

(831) 747-7455

http://minimusinstitute.com/

Monaghan’s Drug-Free Aerobika® Device Helps Reduce the Real-World Impact of Exacerbations in Chronic Obstructive Pulmonary Disease

This study provides the first real-world evidence for the benefits of using the Aerobika® device in reducing exacerbation-related emergency department visits and hospital readmissions.

Syracuse, NY, USA — Monaghan Medical Corporation (MMC) (http://www.monaghanmed.com), today announced the publication of a study in Pulmonary Therapy showing that treatment with Monaghan’s Aerobika® device can significantly reduce the recurrence of exacerbations of chronic obstructive pulmonary disease (COPD) in the crucial 30-day period following hospitalization or emergency room visits.(1) The study also showed that per-patient cost of exacerbations was significantly lower in the group using the Aerobika® Oscillating Positive Expiratory Pressure (OPEP) device. This study provides the first real-world evidence for the benefits of using the Aerobika® device in reducing exacerbation-related emergency department visits and hospital readmissions.

COPD is a major (and growing) source of morbidity, mortality and healthcare utilization, with hospitalization for acute exacerbations being the biggest cost driver. Once a patient experiences an exacerbation, the risk of further exacerbation is increased two- to four-fold(2), and many patients experience two or three exacerbations every year.(3-5) As many as one in five patients discharged from hospital following an exacerbation are re-admitted within 30 days.(6)

This retrospective study analyzed hospital database records for 810 COPD Chronic Bronchitis patients who were hospitalized or visited the emergency room, and showed significantly fewer patients given the Aerobika® device experienced moderate-to-severe exacerbations or severe exacerbations compared with matched controls within the critical 30-day follow-up period. The study also showed a statistically significant savings in exacerbation-related costs in the Aerobika® device group compared with the control group for moderate-to-severe and severe exacerbations. The Aerobika® device was given in addition to the patients’ regular COPD treatments.

“This is the first study to evaluate the benefits of any OPEP in a real-world setting. It provides encouraging evidence that the Aerobika® device can help reduce recurrence of exacerbations in high-risk patients over the crucial early 30-day period,” noted Dr. Michael Bauer, Pulmonary Physician, Cooperstown, New York.

Dominic Coppolo, MBA, RRT, FAARC, Vice President Clinical Strategy and Development at Monaghan Medical, explained how the Aerobika® device may provide these benefits: “During an exacerbation, airways are compromised by (among other factors) inflammation and mucus build-up. This can continue to disrupt ventilation mechanics and lung function after the event, and lead to prolonged respiratory impairment. The Aerobika® device, with its proprietary mechanism of action, helps stent open and clear excess mucus from the upper airways, and may also aid drug deposition, providing a potential mechanism of protection from exacerbations.”

The internationally-recognized GOLD guidelines(7) for COPD treatment stress the importance of exacerbation management, stating that a major treatment goal is to ‘minimize the negative impact of the current exacerbation and to prevent subsequent events.’ A recent analysis(2) predicts that the absolute number of COPD cases could increase by between 150% and 220% in the period from 2010 to 2030, with the burden of inpatient care (total annual inpatient days) growing by around 185%. This further underlines this need to address the burden of COPD exacerbations.

About the Aerobika® device study
A retrospective cohort study utilizing patient data from the U.S. hospital Charge Detail Master (CDM) claims database (data selection period between 1 September 2013 and 31 August 2015). This real-word study involved 810 COPD patients with a diagnosis of chronic bronchitis, 405 receiving treatment with the Aerobika® device and 405 matched controls, (propensity matched to reduce bias and mimic randomization). The data showed significantly fewer patients given the Aerobika® device experienced moderate-to-severe exacerbations (18.5% vs 25.7%, p=0.014) or severe exacerbations (13.5% vs 19.0%; p < 0.046) compared with matched controls over the 30-day follow-up period, with consequent reductions in costs.

About the Aerobika® Device
The Aerobika® device is hand-held, robust, easy-to-use, and drug-free with a proprietary mode of action. When the patient exhales through the device, intermittent resistance creates a unique pressure-oscillation dynamic, which expands the airways, helps expel the mucus to the upper airways where it can be coughed out, and may also aid in improved drug deposition. The Aerobika® device is designed to function independent of angle of use or flow rate, and allows for a direct aerosol pathway for patients using a nebulizer for medication delivery. The Aerobika® device has been shown to significantly improve forced vital capacity (FVC), 6-min walk distance (6MWD), and St. George's Respiratory Questionnaire (SGRQ) score in COPD patients.(8) The Aerobika® device is available in the U.S. from Monaghan Medical Corporation, and in Canada, Mexico, and select European countries including the UK and Germany through Trudell Medical International. (http://www.monaghanmed.com/Aerobika-OPEP)

About Monaghan Medical Corporation (MMC, USA)
MMC offers leading aerosol drug delivery devices and respiratory management products including AeroEclipse® II BAN, AeroChamber Plus® aVHC and the Aerobika® device exclusively in the United States. MMC’s strength lies in product development around core capabilities in mechanical design complimented by collaboration with a state-of-the-art aerosol research laboratory. MMC focuses on developing cost-efficient, outcome-based solutions for its customers. (http://www.monaghanmed.com)

References:

1. Burudpakdee C et al. Pulm Ther 2017 DOI 10.1007/s41030-017-0027-5. Pub online 6 February 2017.

2. Khakban A, et al. Am J Respir Crit Care Med 2017 Feb 1;195(3):287-291.

3. Balter MS, et al. Can Respir J 2003; 10 (Suppl B):3B-32B.

4. Perera PN, et al. COPD J Chron Obst Pulm Dis 2012;9(2):131-41.

5. Puhan MA, et al. Respir Res 2005;6 (1): 1.

6. Shah T, et al. Chest. 2016 Oct;150(4):916-926.

7. The Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017. Available from: http://goldcopd.org (Last accessed 2 Feb 2017).

8. Svenningsen S, et al. COPD 2016;13(1):66-74.

For clinical inquiries, please contact:
Dominic P. Coppolo, MBA, RRT, FAARC
Vice President of Clinical Strategy and Development
Monaghan Medical Corporation
1-800-343-9071

Protecting Patients and Preventing Drug Diversion: Senator Alloway, Representative Nesbit Introduce Pennsylvania Orthopaedic Society’s E-prescribing Legislation

Today, State Senator Richard Alloway and State Representative Tedd Nesbit announced the introduction of legislation to mandate the electronic prescribing of opioid medications.

Harrisburg, PA, February 06, 2017 – Today, State Senator Richard Alloway and State Representative Tedd Nesbit announced the introduction of legislation to mandate the electronic prescribing of opioid medications. The bill is an initiative of the Pennsylvania Orthopaedic Society (POS). Society President Patrick Smith, MD, as well as POS board members, joined legislators in the Main Capitol Rotunda to announce the legislation.

“We stand with Senator Alloway and Representative Nesbit to advance a solution that works in the fight against opioid addiction,” Smith said. “Opioid e-prescribing will absolutely reduce drug diversion due to written prescriptions being lost, stolen or sold. It just plain makes sense in 2017. We thank Senator Alloway, Representative Nesbit and all the other legislators who have joined us today to gain this vital patient protection measure.”

Currently, Pennsylvania law requires opioid prescriptions to be handwritten. A vestige of the pre-internet era, this statute has not been updated since the 1990s. Although physicians may prescribe all other medicine by electronic means, opioids must still be prescribed by handwritten prescriptions. The Alloway and Nesbit bills (SB 299 and HB 353) ?will bring opioid prescribing into the 21st Century.

“Patients and physicians throughout the Commonwealth can feel more secure now that legislative action is pending on opioid e-prescribing,” Smith said. “Paper scripts will no longer put our communities at risk of drug diversion and hamper patient care. We respectfully request the General Assembly to quickly move this solution that works.”

In addition to reducing drug diversion, opioid e-prescribing will add to patient convenience. Like with other medications, opioid e-prescribing will reduce patient wait times in pharmacies. It will also increase patient security by eliminating the risk of opioid prescriptions being stolen.

“There are a multitude of reasons for the current opioid addiction crisis and the General Assembly took important steps last session to turn the tide against it. Opioid e-prescribing is a simple and effective solution and should be added to the arsenal of weapons available to physicians to combat the crisis,” Smith concluded.

Advocating for excellence in the practice of orthopaedic medicine, POS is a professional medical specialty organization representing more than 1000 orthopaedic surgeons across Pennsylvania. For more information on the importance of bone, joint and muscle health at every age, visit www.paorthosociety.org.

Contact:

Steven Infanti

PA Orthopaedic Society

Harrisburg, PA 17101

717-909-8901

justmehbg@earthlink.net

http://www.paorthosociety.org

New York’s Health Agency (NYSDOH) Cited in Iraq War’s Blowback

New York, NY, 2016-Dec-31 — /REAL TIME PRESS RELEASE/ — As the Iraq War’s official end on December 18, 2011 marks its fifth anniversary, many questions remain on its fallouts. New York’s French-American community is one of them, as it remembers its blacklisting when France opted out of attacking Iraq.

Choosing diplomatic pressure rather than “shock and awe” ignited fury for many in New York. The call for anti-French boycotts resonated in tabloids as pictures of New Yorkers spilling wines in gutters vied with accusations of an ally’s betrayal and cowardice. Information can be found by googling “New York’s French boycotts and Iraq,” and “Freedom fries.”

How effective were the boycotts? “Very much so, even devastating,” says French consulate’s official physician and mental health coordinator at the time, Gérard Sunnen, MD, “the French-American community of New York was stunned by their virulence. Why, many wondered, did they materialize only in New York, in striking contrast to the rest of the country?”

“Targeted were all manner of French-American businesses, from Air France to bakeries, as rosters of marked companies circulated widely. Earliest felled were restaurants, whose sales plummeted by as much as half. Like dominoes, they closed their doors, dismissing their workers. Called by many the “consulate’s darkest hour,” it went on for weeks, interminable months, and still resonates today.”

“As layoffs mounted,” Dr. Sunnen added, “so did their mental health consequences, from all manner of stress reactions to self-destructive depressions. And workers suddenly out of work could not find employment because no one would take them. The consulate’s social services department work load soared to levels never attained before.”

Faced with this onslaught, the New York State Department of Health (NYSDOH) was repeatedly contacted to lend the community its medical and mental health assistance. In addition, New York state and city top officials were insistently asked to add their voice to call off the boycotts. All appeals remained unanswered and, for reasons of non-assistance and abandonment of responsibility, this matter was eventually reported and filed in New York and Federal courts.

Dr. Sunnen, who also cites his experience as a Vietnam-era U.S. veteran, concludes, “history needs constant reckoning, otherwise it can remain a fable. These events are now brought to light so that long-term allies can better understand the meaning of their relationship.”

References:

Gérard Sunnen, MD: www.triroc.com/sunnen
Supreme Court, State of New York, No. 102194/2012
U.S. District Court, Southern District of NY 12 Civ. 3417
U.S. Court of Appeals, 2nd Circuit 13-465cv
U.S. Health and Human Services (HHS) 1:13-cv-1242
New York State Division of Human Rights (NYSDHR) No. 10181422
National Transportation Safety Board (NTSB) No. DCA96MA070

Contact-Details: Gerard Sunnen, MD

Monterey Peninsula Surgery Centers has Long Played Leading Role in Promoting Outpatient Surgery, Efforts Spotlighted in National News Story in New York Times

Thomas Wilson, CEO of Monterey Peninsula Surgery Centers, one of the largest locally owned and operated outpatient surgery organizations in the U.S., has long played a leading role in promoting the benefits of outpatient surgery.

Monterey, CA, December 30, 2016 — Thomas Wilson, CEO of Monterey Peninsula Surgery Centers, one of the largest locally owned and operated outpatient surgery organizations in the U.S., has long played a leading role in promoting the benefits of outpatient surgery.

The work of industry leaders Wilson and MPSC is symbolic of what the Ambulatory Surgery Center industry can achieve, and was spotlighted in a recent article published by the New York Times. The article discusses the ongoing debate over whether Medicare should pay for knee replacement surgery in free-standing surgery centers or outpatient facilities. Wilson, past-president of the Ambulatory Surgery Center Association (ASCA), presented compelling evidence to support this assertion including a lower infection rate when compared to surgeries performed in a hospital setting, sky-high patient satisfaction scores and significant cost savings.

This could save Medicare hundreds of millions of dollars annually. MPSC, located in Monterey, California, performs approximately 200 total joint replacement surgeries per year, with infection rates three times lower than similar surgeries performed in hospitals. The age of patients receiving total joint replacements at MPSC ranges from 38 to 82 years old, with the average age of 59. This compares to the national average of 62. He asserts most patients receiving a total joint replacement are not sick and do not need to be surrounded by sick people and thus an outpatient facility is an ideal choice.

How can you tell if a person is a good candidate for outpatient joint replacement surgery? Wilson says the best candidates have a low to moderate body mass index, healthy heart and lungs and a good social support system. A patient meeting these criteria is teamed with a friend or family member who functions as a coach. The patient and coach attend an educational session before the operation and learn about the anatomy of the procedure, how the patient’s pain will be successfully managed without opioids or narcotics, and will undergo the recovery process in the comfort of their own home. The major difference in outpatient surgery is that the patient spends one night in the facility and goes home with a physical therapist visiting the patient soon thereafter. According to Wilson, this is possible because of surgical advances with minimally invasive techniques and the use of long-lasting, non-addictive anesthetics. Many hospitals are adopting these innovations and sending total joint replacement patients home after one or two days in the facility.

.

As a leading proponent of ASCs and outpatient surgery, Wilson was contacted by the New York Times to represent the ASC industry and relate MPSC’s experience with TJR cases as it relates to Medicare’s position on outpatient knee surgery.

A debate has been raging nationally in the medical community regarding this issue, with physicians weighing in on both sides. The Times’ story said the issue “is sowing deep discord in the medical world, and the debate is as much about money as medicine.”

The article noted that demand for knee and hip replacement surgery is growing — 1,000,000 are performed each year in the U.S. — and that number is likely to grow to three million annually by 2030, “making these complex and expensive operations some of surgery’s biggest potential growth markets,” said the Times.

The article headlined “Should Medicare Allow Outpatient Knee Replacement? Doctors Are Deeply Split,” was written by Christina Jewett, a senior correspondent for Kaiser Health News, and was posted to the newspaper’s website on Dec. 20 and appeared in print on Dec. 21 on Page B1 of the New York edition.

Presented with such evidence by Wilson and board certified orthopedic surgeon Sohrab Gollogly of Monterey Spine and Joint in 2016, the Health and Human Services (HHS) Advisory Panel that recommends outpatient payment policies to Medicare officials, unanimously recommended that Medicare remove the total knee replacement procedure from the inpatient only list, effectively allowing it to be performed in the outpatient setting.

Opponents of the change by Medicare say that there are concerns that moving surgery out of hospitals will force vulnerable patients into emergency rooms with uncontrolled pain, blood clots or other complications.

But proponents such as MPSC’s Wilson say the change will give patients more choice and potentially better care and save Medicare hundreds of millions of dollars. And, according to recent rule-making documents, an “overwhelming majority” of those who commented said they want to allow the operations out of hospitals.

In December 2016, the Secretary of HHS did not adopt the recommendation. However approval could occur in 2017 under the Donald J. Trump administration. President elect Trump and Tom Price MD, his selection for Secretary of HHS, have suggested they favor limiting government controls and fostering innovation and increased competition in healthcare.

In recent months, Medicare has shown a strong interest in outpatient knee replacements, noting the potential for “overall improved outcomes” as well as the potential savings for the government program.

Many doctors, however, caution that not all patients are candidates for outpatient surgery, such as those who are frail or have chronic health issues, live alone or in a dwelling with stairs, and don’t have good caretaking at home.

“While we realize this can be good for some patients, it’s not for all patients and all locations,” says Dr. Thomas C. Barber, the chairman of the American Academy of Orthopedic Surgeons’ advocacy council. Wilson agrees that outpatient total joint replacement is not for all, however to deny it to those who seek it is unjust and unwise public policy.

About Thomas D. Wilson

Mr. Wilson is CEO of the Monterey Peninsula Surgery Centers, which has partnered with two local hospitals and 90 surgeons and is one of the largest locally owned independent surgical services organizations in California. He leads the Minimus Institue, the destination medicine division of MPSC, as patients have traveled from 47 states and 10 countries for outpatient surgery at MPSC over the last five years. Wilson and Scott Leggett founded Global 1, one of the largest medical service organizations in the country providing commercially insured transparent all inclusive Bundled Payments through a network of 53 ASCs and over 350 physicians in California.

Mr. Wilson is a past president of Ambulatory Surgery Center Association, the California Surgery Center Association and is Insurance Commissioner Dave Jones’s appointee to the California Insurance Guarantee Association Board of Governors.

Tom Wilson received his undergraduate degree from Utah State University and a master’s degree at the U.C. Berkeley Hospital Administration program.

Background on MPSC:

MPSC and its surgeons are recognized leaders in outpatient surgical care as measured by the high demand for its services, extremely low infection rates, 99% patient satisfaction scores and affordable, transparent pricing. It is known for performing complex surgery, including total joint replacements, major spine surgeries, hysterectomies, breast reconstruction and thyroidectomiesin the outpatient setting. In excess of 31,500 surgical procedures in 13 specialties are performed annually at MPSC by its 190 physicians on staff.

About Minimus Institute:

Wilson also founded and heads the Minimus Institute, a national state-of-the-art concierge surgical institute located in a beautiful setting on California’s Central Coast, providing patients access to world-class surgeons. Offering transparent pricing and clear, comprehensive outcome information and patient-satisfaction scores, Minimus demystifies the surgical-care experience allowing patients to make the most informed decisions about their care.

Contact:

Marci Bracco Cain

Chatterbox PR

Salinas, CA 93901

(831) 747-7455

http://www.chatterboxpublicrelations.com

Dakota Dental Announces Tips to Prepare for a Dental Emergency While Traveling During the Holidays

Dakota Dental gives tips on how to prevent and be prepared for dental emergencies this holiday season.

Apple Valley, MN, USA — Dakota Dental offers tips and information on how to handle dental emergencies during the holidays, and what patients can do to prevent those emergencies from occurring during the holidays. This holiday season, people are likely focused on gift lists, wrapping paper, favorite recipes, family, and travel plans. What may not cross their minds is what to do in the case of a dental emergency during their holiday travels, while they’re away from home and far from their regular dentist.

Some common dental issues that may come up while away from home include toothaches, cracked or broken teeth, or teeth getting knocked out. None of these are pleasant while traveling, but there are some ways to treat these ailments while away from home. For toothaches, rinsing with warm water and gently flossing can help to try and remove any debris that is caught and may be causing discomfort. However, if that doesn’t help, it may be a good idea to call a dentist.

For broken or cracked teeth, apply cold compresses to control swelling and go to a dentist as soon as possible. And for a knocked out tooth, hold it by the crown and rinse the root with water if it’s dirty. If you can’t hold the tooth in its socket, put the tooth in milk and get to a dentist for emergency dental work as soon as you can.

Though some dental emergencies can’t be avoided, there are some dental preventive care measures patients can take to reduce the chances of needing emergency dentistry services this holiday season. Especially if you have a history of dental health issues, make an appointment with the family dentists at Dakota Dental before heading out of town.

The dentists at Dakota Dental can also give patients tips for how to have healthy teeth throughout the holidays. From avoiding hard candies that may chip or crack teeth to ways to prevent toothaches, the dentists at Dakota Dental can help patients make sure their holiday plans don’t get derailed by dental emergencies.

Media Contact:
Dr. Shelley Wakefield
Dakota Dental
14682 Pennock Avenue
Apple Valley, MN 55124
952-431-5774
swakefield@dakotadental.com

Home

No.1 Type 2 Diabetes Book FREE on Kindle November 29 – December 3

New Book Shares Secrets to a Normal Life For Type 2 Diabetics by Following Simple Steps.

Modesto, CA, USA — “Type 2 Diabetes is totally manageable, especially if you can catch it early,” stresses Daryl Wein, author of Type 2 Diabetes: The Owner’s Manual.

The ebook is free on Kindle Nov. 29 thru Dec. 3rd.

“The single most effective thing the patient needs to do is eliminate or at least minimize their carb intake. I have Type 2 Diabetes myself and went nine years living a very healthy life without medicine because I followed a correct diet which did not allow for sugar or carbs.”

A clinical laboratory scientist for more than 20 years and a Physician Assistant for 17 years, Wein started extensive research on Type 2 Diabetes when he himself was diagnosed with the disease.

After directing successful treatment for many hundreds of patients by informing them of the correct diet for them, Wein decided to share those secrets with patients and physicians alike in his new book Type 2 Diabetes: The Owner’s Manual (ISBN 978-1522858270, CreateSpace 2016, 159 pages, available on Amazon $11.99 paperback and Audio Book (regularly $6.99 on Kindle but FREE thru Dec. 3rd).

“To my knowledge my book is the only simple owner’s manual for Type 2 Diabetes,” says Wein. “It teaches readers to utilize first the most effective option available to manage their disease and then to fine-tune sugar control with medication when and if needed. The Owner’s Manual is very simple to read and understand.”

While working for Central California Bariatric Surgery Daryl Wein made it his objective to help patients reach their needed weight goal via diet instead of surgery and experienced multiple successes including one patient who lost 149 pounds over 22 months simply by avoiding carbohydrates completely.

Wein stresses that if all people with sugar abnormalities (who are not dependent on insulin) followed the simple advice in Type 2 Diabetes: The Owner’s Manual the impact on their overall health would be immense and the savings for healthcare in the U.S. alone would be in the many billions of dollars.

James A. Surrell, M.D. and author of SOS (Stop Only Sugar) Diet, says: “We have an epidemic of Type 2 diabetes in the USA today, primarily as a result of our dietary habits. Follow the excellent guidelines contained in Type 2 Diabetes: The Owner’s Manual and you will significantly improve your overall health.”

A physician in a review on Amazon using the pen name “Schmutz” writes: “The Owner’s Manual is well written, easy to understand in laymen’s terms and very useful. If diabetics followed Daryl’s recommendations, my job would be much easier and their lives healthier and longer.”

A few of the eye-opening pieces of advice given by Wein in his highly-respected book include:

• There is no need to consume any sugar or starches at all
• Natural fruit and fruit juices are not good for diabetics
• Avoid all forms of alcohol when trying to lose weight
• The only fats known to be harmful are trans-fats which are mainly found in shortening and margarine
• Eating fat does not make you fat and eating fat has never been directly associated with heart disease
• Brown sugar has never been healthier than white sugar, only less pure
• There are almost no carbs in any of the artificial sweeteners so they do not contribute to the elevation of blood sugar.
• Monitoring your sugar 2-3 times a day with a finger stick test is costly and a complete waste of time.

A former flight instructor, Wein also enjoys water skiing, swimming, building houseboats, and playing the bass which he did while earning his living as a musician, playing in clubs for three years. He owns a small plane but his latest flight interest is flying industrial drones legally. Daryl and wife Jann have an adult daughter, an adult son, and three grandchildren.

November is National Diabetes Month to help put a spotlight on the disease so individuals, health care professionals, organizations, and communities across the country can bring attention to diabetes and its impact on millions of Americans. Visit: http://www.diabetes.org.

About Daryl Wein
A native of Niles, Michigan, Wein earned a degree as a Medical Technologist/Clinical Laboratory Scientist from USC Medical Center in 1978 and earned a degree as a Family Practice Physician Assistant from UC Davis School of Medicine in 1999. Since 1999, while working as a PA with Dr. David Olson and Dr. Elaine Madayag in internal medicine, Wein also worked as a PA at Stanislaus County Urgent Care, Oak Valley Hospital ER, Central California Bariatric Surgery, as a contractor for California Correctional Health Care System, and for rural health clinics run by Oak Valley Clinics. He also has done some software development, and is credentialed in California to teach community college classes.

Media Contact: For a review copy of Type 2 Diabetes: The Owner’s Manual or to arrange an interview with Daryl Wein contact Scott Lorenz of Westwind Communications Book Marketing by phone at 734-667-2090 or http://www.book-marketing-expert.com.